3rd International Conference on PreHypertension & Cardio Metabolic Syndrome (PreHT 2014)

27 March 2014 to 30 March 2014
Warsaw, Poland

Prehypertension is usually associated with other components of the metabolic syndrome i.e. obesity, glucose intolerance and dyslipidemia. This association is due to common mechanistic pathways and has implications on cardiovascular complications. Diet and exercise with or without drug therapy benefit all components of the metabolic syndrome. Antihypertensive medications may lead to deterioration in glucose tolerance while glucose lowering agents may affect blood pressure. Thus, any discussion about the approach to prehypertension must be done in context to the whole cardio metabolic risk.

The association of multiple CV risk factors enhances rate of progression of end organ damage and affects morbidity and mortality. The presence of multiple risk factors changes the prognosis of the patients and should affect our therapeutic approach- an area with insufficient information and guidelines.

The Conference will aim to deal with all aspects related to early diagnosis, including innovative technologies and treatments and will bring together professionals from the fields of Hypertension, Nephrology, Endocrinology, Internal Medicine, Cardiology and more.

Conference website